132 related articles for article (PubMed ID: 20471254)
1. Tetracyclic sulfones as potent gamma-secretase inhibitors: synthesis and structure-activity relationship studies.
Sasikumar TK; Burnett DA; Asberom T; Wu WL; Bennett C; Cole D; Xu R; Greenlee WJ; Clader J; Zhang L; Hyde L
Bioorg Med Chem Lett; 2010 Jun; 20(12):3645-8. PubMed ID: 20471254
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic sulfones as orally active gamma-secretase inhibitors: synthesis and structure-activity relationship studies.
Sasikumar TK; Qiang L; Burnett DA; Cole D; Xu R; Li H; Greenlee WJ; Clader J; Zhang L; Hyde L
Bioorg Med Chem Lett; 2010 Jun; 20(12):3632-5. PubMed ID: 20493690
[TBL] [Abstract][Full Text] [Related]
3. Design of potent inhibitors of human beta-secretase. Part 1.
Freskos JN; Fobian YM; Benson TE; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Moon JB; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G
Bioorg Med Chem Lett; 2007 Jan; 17(1):73-7. PubMed ID: 17046251
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of tricyclic sulfones as gamma-secretase inhibitors with greatly reduced Notch toxicity.
Xu R; Cole D; Asberom T; Bara T; Bennett C; Burnett DA; Clader J; Domalski M; Greenlee W; Hyde L; Josien H; Li H; McBriar M; McKittrick B; McPhail AT; Pissarnitski D; Qiang L; Rajagopalan M; Sasikumar T; Su J; Tang H; Wu WL; Zhang L; Zhao Z
Bioorg Med Chem Lett; 2010 Apr; 20(8):2591-6. PubMed ID: 20236824
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Fused cyclohexyl sulfones as gamma-secretase inhibitors.
Shaw D; Best J; Dinnell K; Nadin A; Shearman M; Pattison C; Peachey J; Reilly M; Williams B; Wrigley J; Harrison T
Bioorg Med Chem Lett; 2006 Jun; 16(11):3073-7. PubMed ID: 16617016
[TBL] [Abstract][Full Text] [Related]
6. 4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitors.
Churcher I; Beher D; Best JD; Castro JL; Clarke EE; Gentry A; Harrison T; Hitzel L; Kay E; Kerrad S; Lewis HD; Morentin-Gutierrez P; Mortishire-Smith R; Oakley PJ; Reilly M; Shaw DE; Shearman MS; Teall MR; Williams S; Wrigley JD
Bioorg Med Chem Lett; 2006 Jan; 16(2):280-4. PubMed ID: 16275079
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and SAR study of tricyclic sulfones as γ-secretase inhibitors: C-6 and C-8 positions.
Su J; Tang H; McKittrick BA; Xu R; Clader JW; Greenlee WJ; Hyde L; Zhang L
Bioorg Med Chem Lett; 2011 Jun; 21(11):3447-51. PubMed ID: 21515050
[TBL] [Abstract][Full Text] [Related]
8. Molecular-modeling based design, synthesis, and activity of substituted piperidines as gamma-secretase inhibitors.
Gundersen E; Fan K; Haas K; Huryn D; Steven Jacobsen J; Kreft A; Martone R; Mayer S; Sonnenberg-Reines J; Sun SC; Zhou H
Bioorg Med Chem Lett; 2005 Apr; 15(7):1891-4. PubMed ID: 15780628
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and structure-activity relationship of novel orally efficacious pyrazole/sulfonamide based dihydroquinoline gamma-secretase inhibitors.
Truong AP; Aubele DL; Probst GD; Neitzel ML; Semko CM; Bowers S; Dressen D; Hom RK; Konradi AW; Sham HL; Garofalo AW; Keim PS; Wu J; Dappen MS; Wong K; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Nguyen L; Hemphill SS; Bova MP; Bard F; Yednock TA; Basi G
Bioorg Med Chem Lett; 2009 Sep; 19(17):4920-3. PubMed ID: 19660943
[TBL] [Abstract][Full Text] [Related]
10. Novel orally bioavailable gamma-secretase inhibitors with excellent in vivo activity.
Keown LE; Collins I; Cooper LC; Harrison T; Madin A; Mistry J; Reilly M; Shaimi M; Welch CJ; Clarke EE; Lewis HD; Wrigley JD; Best JD; Murray F; Shearman MS
J Med Chem; 2009 Jun; 52(11):3441-4. PubMed ID: 19432431
[TBL] [Abstract][Full Text] [Related]
11. Design of potent inhibitors of human beta-secretase. Part 2.
Freskos JN; Fobian YM; Benson TE; Moon JB; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G
Bioorg Med Chem Lett; 2007 Jan; 17(1):78-81. PubMed ID: 17049233
[TBL] [Abstract][Full Text] [Related]
12. Nitrogen-appended N-alkylsulfonamides as inhibitors of gamma-secretase.
Bergstrom CP; Sloan CP; Wang HH; Parker MF; Smith DW; Zheng M; Hansel SB; Polson CT; Barber LE; Bursuker I; Guss VL; Corsa JA; Barten DM; Felsenstein KM; Roberts SB
Bioorg Med Chem Lett; 2008 Jan; 18(1):175-8. PubMed ID: 18023581
[TBL] [Abstract][Full Text] [Related]
13. Cyclic sulfamide gamma-secretase inhibitors.
Sparey T; Beher D; Best J; Biba M; Castro JL; Clarke E; Hannam J; Harrison T; Lewis H; Madin A; Shearman M; Sohal B; Tsou N; Welch C; Wrigley J
Bioorg Med Chem Lett; 2005 Oct; 15(19):4212-6. PubMed ID: 16054361
[TBL] [Abstract][Full Text] [Related]
14. Carbamate-appended N-alkylsulfonamides as inhibitors of gamma-secretase.
Bergstrom CP; Sloan CP; Lau WY; Smith DW; Zheng M; Hansel SB; Polson CT; Corsa JA; Barten DM; Felsenstein KM; Roberts SB
Bioorg Med Chem Lett; 2008 Jan; 18(2):464-8. PubMed ID: 18178084
[TBL] [Abstract][Full Text] [Related]
15. Macrocyclic inhibitors of beta-secretase: functional activity in an animal model.
Stachel SJ; Coburn CA; Sankaranarayanan S; Price EA; Wu G; Crouthamel M; Pietrak BL; Huang Q; Lineberger J; Espeseth AS; Jin L; Ellis J; Holloway MK; Munshi S; Allison T; Hazuda D; Simon AJ; Graham SL; Vacca JP
J Med Chem; 2006 Oct; 49(21):6147-50. PubMed ID: 17034118
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.
Pu J; Kreft AF; Aschmies SH; Atchison KP; Berkowitz J; Caggiano TJ; Chlenov M; Diamantidis G; Harrison BL; Hu Y; Huryn D; Steven Jacobsen J; Jin M; Lipinski K; Lu P; Martone RL; Morris K; Sonnenberg-Reines J; Riddell DR; Sabalski J; Sun SC; Wagner E; Wang Y; Xu Z; Zhou H; Resnick L
Bioorg Med Chem; 2009 Jul; 17(13):4708-17. PubMed ID: 19443228
[TBL] [Abstract][Full Text] [Related]
17. Discovery of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid β-peptides.
Rueeger H; Lueoend R; Rogel O; Rondeau JM; Möbitz H; Machauer R; Jacobson L; Staufenbiel M; Desrayaud S; Neumann U
J Med Chem; 2012 Apr; 55(7):3364-86. PubMed ID: 22380629
[TBL] [Abstract][Full Text] [Related]
18. Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization.
Cumming J; Babu S; Huang Y; Carrol C; Chen X; Favreau L; Greenlee W; Guo T; Kennedy M; Kuvelkar R; Le T; Li G; McHugh N; Orth P; Ozgur L; Parker E; Saionz K; Stamford A; Strickland C; Tadesse D; Voigt J; Zhang L; Zhang Q
Bioorg Med Chem Lett; 2010 May; 20(9):2837-42. PubMed ID: 20347593
[TBL] [Abstract][Full Text] [Related]
19. Substituted 2-oxo-azepane derivatives are potent, orally active gamma-secretase inhibitors.
Kitas EA; Galley G; Jakob-Roetne R; Flohr A; Wostl W; Mauser H; Alker AM; Czech C; Ozmen L; David-Pierson P; Reinhardt D; Jacobsen H
Bioorg Med Chem Lett; 2008 Jan; 18(1):304-8. PubMed ID: 17983746
[TBL] [Abstract][Full Text] [Related]
20. 3-Substituted gem-cyclohexane sulfone based gamma-secretase inhibitors for Alzheimer's disease: conformational analysis and biological activity.
Jelley RA; Elliott J; Gibson KR; Harrison T; Beher D; Clarke EE; Lewis HD; Shearman M; Wrigley JD
Bioorg Med Chem Lett; 2006 Jul; 16(14):3839-42. PubMed ID: 16682202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]